Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE.
Saved in:
| Title: | Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE. |
|---|---|
| Authors: | Matikas A; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden alexios.matikas@ki.se.; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden., Naume B; Department of Oncology, Oslo University Hospital, Oslo, Norway., Wildiers H; Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium., Sonke G; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Dieci MV; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IRCCS, Padova, Italy., Karakatsanis A; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Section for Breast Surgery, Uppsala University Hospital (Akademiska), Uppsala, Sweden., Andersson A; Department of diagnostics and intervention, oncology, Umeå University, Umeå, Sweden., Barnekow E; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden., Kessler LE; Breast Center, Capio Saint Göran's Hospital, Stockholm, Sweden., Einbeigi Z; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine and Oncology, Southern Älvsborg Hospital, Borås, Sweden., Killander F; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Skåne University Hospital, Lund University, Lund, Sweden., Linderholm B; Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden., Schiza A; Department of Oncology, Uppsala University Hospital and department of Immunology, Genetics and Pathology Uppsala University, Uppsala, Sweden., Valachis A; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden., Nearchou A; Department of Oncology, Mälarsjukhuset, Eskilstuna, Sweden., Engebraaten O; Department of Oncology, Oslo University Hospital, Oslo, Norway., Porojnicu A; Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway., Soland MH; Department of Oncology, Stavanger University Hospital, Stavanger, Norway., Mannsåker B; Department of Oncology, Nordland Hospital Trust, Bodø, Norway., Raj SX; Breast Cancer Unit, Cancer Clinic, University Hospital in Trondheim, Trondheim, Norway., Blix ES; Department of Oncology, University Hospital of North Norway, Tromsø, Norway., Nordstrand CS; Department of Oncology, Møre og Romsdal Hospital Trust, Alesund, Norway., Lambertini M; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy., Vernieri C; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Oncology and Hematology-Oncology Department, University of Milan, Milan, Italy., Punie K; Department of Medical Oncology, Ziekenhuis Aan de Stroom, Wilrijk, Belgium., Sotiriou C; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium., Bergh J; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden., Villacampa G; SOLTI Cancer Research Group, Barcelona, Spain.; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Zouzos A; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden., Hellström M; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden., Hartman J; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden., Foukakis T; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden. |
| Source: | BMJ open [BMJ Open] 2025 Aug 27; Vol. 15 (8), pp. e102626. Date of Electronic Publication: 2025 Aug 27. |
| Publication Type: | Journal Article; Clinical Trial Protocol |
| Journal Info: | Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40866060 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Matikas+A%22">Matikas A</searchLink>; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden alexios.matikas@ki.se.; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Naume+B%22">Naume B</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Wildiers+H%22">Wildiers H</searchLink>; Department of General Medical Oncology and Multidisciplinary Breast Centre, University Hospitals Leuven, Leuven, Belgium.<br /><searchLink fieldCode="AU" term="%22Sonke+G%22">Sonke G</searchLink>; Division of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dieci+MV%22">Dieci MV</searchLink>; Dipartimento di Scienze Chirurgiche, Oncologiche e Gastroenterologiche, Università di Padova, Padova, Italy.; Oncologia 2, Istituto Oncologico Veneto IRCCS, Padova, Italy.<br /><searchLink fieldCode="AU" term="%22Karakatsanis+A%22">Karakatsanis A</searchLink>; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden.; Section for Breast Surgery, Uppsala University Hospital (Akademiska), Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Andersson+A%22">Andersson A</searchLink>; Department of diagnostics and intervention, oncology, Umeå University, Umeå, Sweden.<br /><searchLink fieldCode="AU" term="%22Barnekow+E%22">Barnekow E</searchLink>; Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.; Department of Oncology, Södersjukhuset, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Kessler+LE%22">Kessler LE</searchLink>; Breast Center, Capio Saint Göran's Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Einbeigi+Z%22">Einbeigi Z</searchLink>; Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.; Department of Medicine and Oncology, Southern Älvsborg Hospital, Borås, Sweden.<br /><searchLink fieldCode="AU" term="%22Killander+F%22">Killander F</searchLink>; Division of Oncology and Pathology, Department of Clinical Sciences Lund, Faculty of Medicine, Skåne University Hospital, Lund University, Lund, Sweden.<br /><searchLink fieldCode="AU" term="%22Linderholm+B%22">Linderholm B</searchLink>; Institution of Clinical Sciences, Department of Oncology, Sahlgrenska Academy at Gothenburg University, Gothenburg, Sweden.<br /><searchLink fieldCode="AU" term="%22Schiza+A%22">Schiza A</searchLink>; Department of Oncology, Uppsala University Hospital and department of Immunology, Genetics and Pathology Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Valachis+A%22">Valachis A</searchLink>; Department of Oncology, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.<br /><searchLink fieldCode="AU" term="%22Nearchou+A%22">Nearchou A</searchLink>; Department of Oncology, Mälarsjukhuset, Eskilstuna, Sweden.<br /><searchLink fieldCode="AU" term="%22Engebraaten+O%22">Engebraaten O</searchLink>; Department of Oncology, Oslo University Hospital, Oslo, Norway.<br /><searchLink fieldCode="AU" term="%22Porojnicu+A%22">Porojnicu A</searchLink>; Department of Oncology, Drammen Hospital, Vestre Viken Hospital Trust, Drammen, Norway.<br /><searchLink fieldCode="AU" term="%22Soland+MH%22">Soland MH</searchLink>; Department of Oncology, Stavanger University Hospital, Stavanger, Norway.<br /><searchLink fieldCode="AU" term="%22Mannsåker+B%22">Mannsåker B</searchLink>; Department of Oncology, Nordland Hospital Trust, Bodø, Norway.<br /><searchLink fieldCode="AU" term="%22Raj+SX%22">Raj SX</searchLink>; Breast Cancer Unit, Cancer Clinic, University Hospital in Trondheim, Trondheim, Norway.<br /><searchLink fieldCode="AU" term="%22Blix+ES%22">Blix ES</searchLink>; Department of Oncology, University Hospital of North Norway, Tromsø, Norway.<br /><searchLink fieldCode="AU" term="%22Nordstrand+CS%22">Nordstrand CS</searchLink>; Department of Oncology, Møre og Romsdal Hospital Trust, Alesund, Norway.<br /><searchLink fieldCode="AU" term="%22Lambertini+M%22">Lambertini M</searchLink>; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genova, Italy.; Department of Internal Medicine and Medical Specialties (DIMI), School of Medicine, University of Genova, Genova, Italy.<br /><searchLink fieldCode="AU" term="%22Vernieri+C%22">Vernieri C</searchLink>; Medical Oncology Department, Breast Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy.; Oncology and Hematology-Oncology Department, University of Milan, Milan, Italy.<br /><searchLink fieldCode="AU" term="%22Punie+K%22">Punie K</searchLink>; Department of Medical Oncology, Ziekenhuis Aan de Stroom, Wilrijk, Belgium.<br /><searchLink fieldCode="AU" term="%22Sotiriou+C%22">Sotiriou C</searchLink>; Breast Cancer Translational Research Laboratory, Institut Jules Bordet, Hôpital Universitaire de Bruxelles, Université Libre de Bruxelles, Brussels, Belgium.<br /><searchLink fieldCode="AU" term="%22Bergh+J%22">Bergh J</searchLink>; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Villacampa+G%22">Villacampa G</searchLink>; SOLTI Cancer Research Group, Barcelona, Spain.; Statistics Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Zouzos+A%22">Zouzos A</searchLink>; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Hellström+M%22">Hellström M</searchLink>; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Hartman+J%22">Hartman J</searchLink>; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Foukakis+T%22">Foukakis T</searchLink>; Breast Center, Theme Cancer, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden.; Department of Oncology/Pathology, Karolinska Institutet, Stockholm, Sweden. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101552874%22">BMJ open</searchLink> [BMJ Open] 2025 Aug 27; Vol. 15 (8), pp. e102626. <i>Date of Electronic Publication: </i>2025 Aug 27. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Clinical Trial Protocol – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101552874 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-6055 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220446055%22">20446055 </searchLink><i>NLM ISO Abbreviation: </i>BMJ Open <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40866060 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1136/bmjopen-2025-102626 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e102626 Titles: – TitleFull: Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Matikas A – PersonEntity: Name: NameFull: Naume B – PersonEntity: Name: NameFull: Wildiers H – PersonEntity: Name: NameFull: Sonke G – PersonEntity: Name: NameFull: Dieci MV – PersonEntity: Name: NameFull: Karakatsanis A – PersonEntity: Name: NameFull: Andersson A – PersonEntity: Name: NameFull: Barnekow E – PersonEntity: Name: NameFull: Kessler LE – PersonEntity: Name: NameFull: Einbeigi Z – PersonEntity: Name: NameFull: Killander F – PersonEntity: Name: NameFull: Linderholm B – PersonEntity: Name: NameFull: Schiza A – PersonEntity: Name: NameFull: Valachis A – PersonEntity: Name: NameFull: Nearchou A – PersonEntity: Name: NameFull: Engebraaten O – PersonEntity: Name: NameFull: Porojnicu A – PersonEntity: Name: NameFull: Soland MH – PersonEntity: Name: NameFull: Mannsåker B – PersonEntity: Name: NameFull: Raj SX – PersonEntity: Name: NameFull: Blix ES – PersonEntity: Name: NameFull: Nordstrand CS – PersonEntity: Name: NameFull: Lambertini M – PersonEntity: Name: NameFull: Vernieri C – PersonEntity: Name: NameFull: Punie K – PersonEntity: Name: NameFull: Sotiriou C – PersonEntity: Name: NameFull: Bergh J – PersonEntity: Name: NameFull: Villacampa G – PersonEntity: Name: NameFull: Zouzos A – PersonEntity: Name: NameFull: Hellström M – PersonEntity: Name: NameFull: Hartman J – PersonEntity: Name: NameFull: Foukakis T IsPartOfRelationships: – BibEntity: Dates: – D: 27 M: 08 Text: 2025 Aug 27 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2044-6055 Numbering: – Type: volume Value: 15 – Type: issue Value: 8 Titles: – TitleFull: BMJ open Type: main |
| ResultId | 1 |